RIGHT OF FIRST REFUSAL AGREEMENTRight of First Refusal Agreement • November 1st, 2022 • SAB Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 1st, 2022 Company IndustryThis Right of First Refusal Agreement (“Agreement”) is made as of October 26, 2022 (“Effective Date”) by and among Emergent BioSolutions Canada, Inc. (“Emergent”) and Sab Biotherapeutics, Inc. (“Customer”). Customer and Emergent may be individually referred to as a Party or collectively referred to as the Parties.
MANUFACTURING OPTION AGREEMENTManufacturing Option Agreement • November 1st, 2022 • SAB Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 1st, 2022 Company IndustryThis Manufacturing Option Agreement (“Agreement”) is made as of October 26, 2022 (“Effective Date”) by and among Emergent BioSolutions Canada, Inc. (“Emergent”) and Sab Biotherapeutics, Inc. (“Customer”). Customer and Emergent may be individually referred to as a Party or collectively referred to as the Parties.